X @Bloomberg

Viking Therapeutics plunged in early trading on Tuesday after its experimental obesity pill disappointed in a mid-stage study, marking another weaker-than-expected result for an oral alternative to popular weight-loss injections https://t.co/7dQrwfjyjo ...